International
Tempus: Study presented at ESMO evaluated more than 60,000 advanced NSCLC cases and found greater than 80% sensitivity across all 12 biomarkers using routine H&E pathology images CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc....
From Deciphex on LinkedIn: Our founder and CEO Donal O'Shea was on stage at the International AI Summit in Dublin yesterday, the flagship AI event of Ireland’s EU Council Presidency. He joined Áine Kerr, Dorothy Creaven (Jentic), Eoin...
Lunit and Discovery Life Sciences: Collaboration expands access to Lunit's AI-powered pathology platform by combining it with Discovery Life Sciences' global biospecimen and specialty laboratory capabilities, enabling standardized tissue...
Aiforia Technologies Oyj, Press Release, October 9, 2026, at 8:00 a.m. EEST Aiforia, a developer of AI-powered solutions for cancer diagnostics, has won the prestigious "Vuoden Digiteko 2026" (Digital Innovation of the Year) public vote in...
Trubun Health: Digital pathology platform registered for use in supporting primary diagnosis, opening a new market for Tribun Health and its partners PARIS, FR / ACCESS Newswire / October 6, 2026 / Tribun Health, a global provider of digital...
Agendia Podium presentation by Co-Founder and Chief Research Officer Laura van ’t Veer introduces an AI-driven approach to MammaPrint Two additional poster presentations from the FLEX Study IRVINE, Calif. &...
